摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 2-ethoxy-4-hydroxybenzoate | 741699-00-3

中文名称
——
中文别名
——
英文名称
methyl 2-ethoxy-4-hydroxybenzoate
英文别名
——
methyl 2-ethoxy-4-hydroxybenzoate化学式
CAS
741699-00-3
化学式
C10H12O4
mdl
——
分子量
196.203
InChiKey
FCLORMUOKKFZIL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • AMINO ALCOHOL DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USE OF THESE
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:EP1679304A1
    公开(公告)日:2006-07-12
    The present invention provides compounds represented by general formula (I): a prodrug thereof, or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; each of R2 and R3 is independently hydrogen or lower alkyl; each of R4, R5 and R6 is independently hydrogen, halogen, lower alkyl or lower alkoxy; R7 is hydrogen or lower alkyl; R8 is hydrogen, halogen, lower alkyl, lower alkoxy, etc; R9 is -COR10, -A1-COR10, -O-A2-COR10, etc; Ar is optionally substituted phenyl or heteroaryl; and A is a bond, -OCH2-, etc, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
    本发明提供了由通式(I)表示的化合物: 其前药,或其药用可接受的盐,其中R1是氢或较低的烷基;R2和R3中的每一个独立地是氢或较低的烷基;R4、R5和R6中的每一个独立地是氢、卤素、较低的烷基或较低的烷氧基;R7是氢或较低的烷基;R8是氢、卤素、较低的烷基、较低的烷氧基等;R9是-COR10、-A1-COR10、-O-A2-COR10等;Ar是可选择地取代的苯基或杂环芳基;A是键,-OCH2-等,具有强效和选择性的β3-肾上腺素受体刺激活性。本发明还提供了含有所述化合物的药物组合物,以及其用途。
  • Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
    申请人:Kobayashi Junichi
    公开号:US20060128807A1
    公开(公告)日:2006-06-15
    The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R 1 and R 2 are each hydrogen or lower alkyl; R 3 , R 4 , R 5 and R 6 are each hydrogen, halogen, lower alkyl or lower alkoxy; R 7 and R 8 are each hydrogen, halogen, lower alkyl, halo-lower alkyl, lower alkoxy, cycloalkyl, aryl, heteroaryl, cyano, a hydroxyl group, lower acyl, carboxy or the like; R 9 is —C(O)—R 10 , -A 1 -C(O)—R 10 , —O-A 2 -C(O)—R 10 or a tetrazol-5-yl group, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
    本发明提供一般式(I)所表示的化合物或其药学上可接受的盐,其中R1和R2均为氢或较低的烷基;R3、R4、R5和R6均为氢、卤素、较低的烷基或较低的烷氧基;R7和R8均为氢、卤素、较低的烷基、卤代较低的烷基、较低的烷氧基、环烷基、芳基、杂芳基、基、羟基、较低的酰基、羧基或类似物;R9为—C(O)—R10、-A1-C(O)—R10、—O-A2-C(O)—R10或四唑-5-基团,其表现出强效和选择性的β3肾上腺素能受体刺激活性。本发明还提供含有该化合物的药物组合物及其用途。
  • Amino alcohol derivatives, medicinal composition containing the same, and use of these
    申请人:Kobayashi Junichi
    公开号:US20070078184A1
    公开(公告)日:2007-04-05
    The present invention provides compounds represented by general formula (I): a prodrug thereof, or pharmaceutical acceptable salts thereof, wherein R 1 is hydrogen or lower alkyl; each of R2 and R3 is independently hydrogen or lower alkyl; each of R 4 , R 5 and R 6 is independently hydrogen, halogen, lower alkyl or lower alkoxy; R 7 is hydrogen or lower alkyl; R 8 is hydrogen, halogen, lower alkyl, lower alkoxy, etc; R 9 is —COR 10 , -A 1 -COR 10 , —O-A 2 -COR 10 , etc; Ar is optionally substituted phenyl or heteroaryl; and A is a bond, —OCH 2 —, etc, which exhibit potent and selective β3-adrenoceptor stimulating activities. The present invention also provides pharmaceutical compositions containing said compound, and uses thereof.
    本发明提供了由通式(I)表示的化合物:其前体,或其药学上可接受的盐,其中R1是氢或较低的烷基;R2和R3各自独立地是氢或较低的烷基;R4,R5和R6各自独立地是氢,卤素,较低的烷基或较低的烷氧基;R7是氢或较低的烷基;R8是氢,卤素,较低的烷基,较低的烷氧基等;R9是-COR10,-A1-COR10,-O-A2-COR10等;Ar是可选取代的苯基或杂环芳基;A是键,-OCH2-等,这些化合物表现出潜在和选择性的β3-肾上腺素能受体刺激活性。本发明还提供了含有上述化合物的药物组合物及其用途。
  • Modified polyester and method of manufacturing same
    申请人:POLYPLASTICS CO. LTD.
    公开号:EP0556050A1
    公开(公告)日:1993-08-18
    A modified polyester having excellent mechanical properties such as tenacity which emits only a small amount of a gas by decomposition during use at elevated temperatures for a long period of time and only a small amount of a sublimate in the course of melting it and which is suitable particularly for use as the material of a molding for an electric or electronic component, or a packaging material such as film, sheet or container, characterized by its formation from: (A) an acid component mainly comprising terephthalic acid, 2,6-naphthalenedicarboxylic acid or a lower alcohol ester thereof, (B) a diol component mainly comprising an alkylene glycol having 2 to 8 carbon atoms, and (C) an aromatic sulfonic acid compound of the following general formula (1):         (1)   HO(RO)n-Ar-SO₃M wherein Ar represents a benzene or naphthalene ring, n represents an integer from 1 to 10, R represents a group selected from among alkylenes having 2 or 3 carbon atoms and when n is 2 or more, R may be the same as or different from one another, and M represents an alkali metal selected from lithium, sodium and potassium, and satisfying the following formulae (2) and (3):         (2)   0.25 ≦ x ≦ 100 (meq/kg)         (3)   2 ≦ (x/[CEG]) x 100 ≦ 150 (%) wherein x represents the amount of the aromatic sulfonic acid compound represented by the above general formula (1) introduced thereinto and [CEG] represents the amount of the carboxy end groups, and x and [CEG] are each expressed in milliequivalent (meq/kg) per kilogram of the polymer. In a method of manufacturing the modified polyester, the said components (A), (B) and (C) are reacted together in the presence of a catalyst, component (C) preferably being added before before completion of esterification or transesterification of said acid and diol components (A) and (B).
    一种改性聚酯,具有优异的机械性能(如韧性),在高温下长期使用时仅分解释放出少量气体,在熔化过程中仅释放出少量亚硝酸盐,特别适合用作电气或电子元件的模塑材料,或薄膜、片材或容器等包装材料,其特征在于它是由以下物质形成的: (A) 酸组分,主要包括对苯二甲酸、2,6-甲酸或其低级醇酯、 (B) 主要由具有 2 至 8 个碳原子的烷二醇组成的二元醇成分,以及 (C) 下述通式(1)的芳香族磺酸化合物: (1) HO(RO)n-Ar-SO₃M 其中 Ar 代表苯环或环、 n 代表 1 至 10 的整数、 R 代表选自具有 2 或 3 个碳原子的亚烷基中的一个基团,当 n 为 2 或 2 个以上时,R 可彼此相同或不同,以及 M 代表选自的碱属,并满足下式(2)和(3): (2) 0.25 ≦ x ≦ 100 (meq/kg) (3) 2 ≦ (x/[CEG]) x 100 ≦ 150 (%) 其中 x 代表引入上述通式(1)所代表的芳香族磺酸化合物的量,[CEG] 代表羧基末端基团的量,以及 x和[CEG]分别以每公斤聚合物的毫当量(meq/kg)表示。 在制造改性聚酯的方法中,所述组分(A)、(B)和(C)在催化剂存在下一起反应,组分(C)最好在所述酸和二元醇组分(A)和(B)完成酯化或酯交换之前加入。
  • AMINO ALCOHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE THEREOF
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:EP1593666B1
    公开(公告)日:2008-07-02
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫